Improved insulin sensitivity by bezafibrate in rats: Relationship to fatty acid composition of skeletal-muscle triglycerides

Diabetes

Volumn 46, Issue 3, 1997, Pages 348-353

  Matsui, Hideo ^a   Okumura, Kenji ^a   Kawakami, Kei ^a   Hibino, Michitaka ^a   Toki, Yukio ^a   Ito, Takayuki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BEZAFIBRATE; FATTY ACID; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; FATTY ACID SYNTHESIS; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0031051533     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.3.348     Document Type: Article

References (47)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
3. Morris AD, Petrie JR, Connell JMC: Insulin and hypertension. J Hypertens 12:633-642, 1994
4. Reaven GM: Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 90 (Suppl. 2A):7-12, 1991
5. Bruce R, Godsland I, Walton C, Crook D, Wynn V: Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity. Metabolism 43:1275-1281, 1994
6. McKane WR, Stevens AB, Woods R, Andrews WJ, Henry RW, Bell PM: The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism 39:1240-1245, 1990
7. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS: Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237:885-888, 1987
8. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW: Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipid. Diabetes 40:280-289, 1991
9. Pan DA, Storlien LH: Dietary lipid profile is a determinant of tissue phospholipid fatty acid composition and rate of weight gain in rats. J Nutr 123:512-519, 1993
10. Ntambi JM: Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver. J Biol Chem 267:10925-10930, 1992
11. Clarke SD, Jump DB: Regulation of gene transcription by polyunsaturated fatty acids. Prog Lipid Res 32:139-149, 1993
12. Pelikánová T, Kohout M, Válek J, Base J, Kazdová L: Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism 38:188-192, 1989
13. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV: The relation between insulin sensitivity and the fatty acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238-244, 1993
14. Pan DA, Lillioja S, Milner MR, Kriketos AD, Baur LA, Bogardus C, Storlien LH: Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 96:2802-2808, 1995
15. Vessby B, Tengblad S, Lithell H: Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37:1044-1050, 1994
16. Zavaroni I, Sander S, Scott S, Reaven GM: Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 29:970-973, 1980
17. Tobey TA, Mondon CE, Zavaroni I, Reaven GM: Mechanism of insulin resistance in fructose-fed rats. Metabolism 31:608-612, 1982
18. Hwang IS, Ho H, Hoffman BB, Reaven GM: Fructose-induced insulin resistance and hypertension in rats. Hypertension 10:512-516, 1987
19. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW: Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 49:1155-1163, 1989
20. Storlien LH, Oakes ND, Pan DA, Kusunoki M, Jenkins AB: Syndromes of insulin resistance in the rat: inducement by diet and amelioration with benfluorex. Diabetes 42:457-462, 1993
21. Olsson AG, Lang PD, Vollmar J: Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemia. Atherosclerosis 55:195-203, 1985
22. Monk JP, Todd PA: Bezafibrate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidemia. Drugs 33:539-576, 1987
23. Shepherd J: Mechanism of action of fibrates. Postgrad Med J 69 (Suppl. 1):34-41, 1993
24. Kobayashi J, Takahashi K, Tashiro J, Shirai K, Saito Y, Yoshida S, Hashimoto H, Fukumachi I, Niihara K, Sasaki N: Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia. Arzneimittelforschung 44:145-148, 1994
25. Miller RD: Atromid in the treatment of postclimacteric diabetes. J Atheroscler Res 3:694-700, 1963
26. Barnett D, Craig JG, Robinson DS, Perenna Rogers M: Effect of clofibrate on glucose tolerance in maturity onset diabetes. Br J Clin Pharmacol 4:455-458, 1977
27. Kobayashi M, Shigeta Y, Hirata Y, Omori Y, Sakamoto N, Nambu S, Baba S: Improvement of glucose tolerance in NIDDM by clofibrate: randomized double-blind study. Diabetes Care 11:195-499, 1988
28. Jones IR, Swai A, Taylor R, Miller M, Laker MF, Alberti KGMM: Lowering of plasma glucose concentrations with bezafibrate in patients with moderately control NIDDM. Diabetes Care 13:855-863, 1990
29. Mikhailidis DP, Mathur S, Barradas MA, Dandoma P: Bezafibrate retard in type II diabetes patients: effects of hemostasis and glucose homeostasis. J Cardiovasc Pharmacol 16 (Suppl. 9):26-29, 1990
30. Inoue I, Takahashi K, Katayama S, Akabane S, Negishi K, Suzuki M, Ishii J, Kawazu S: Improvement of glucose tolerance by bezafibrate in on-obese patients with hyperlipidemia and impaired glucose tolerance. Diabetes Res Clin Pract 25:199-205, 1994
31. Okumura K, Yamada Y, Kondo J, Ishida A, Hashimoto H, Ito T, Ogawa K, Kitoh J: Increased 1,2-diacylglycerol content in myopatic hamster hearts at a prenecrotic stage. Life Sci 43:1371-1377, 1988
32. Morrison WR, Smith LM: Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5:600-608, 1964
33. Mondon CE, Reaven GM: Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 37:303-305, 1988
34. Kobayashi R, Nagano M, Nakamura F, Higashi J, Fujioka Y, Ikegami H, Mikami H, Kawaguchi N, Onishi S, Ogihara T: Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats. Hypertension 21:1051-1055, 1993
35. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000-1007, 1981
36. Dang AQ, Faas FH, Lee JA, Carter WJ: Altered fatty acid composition in the plasma, platelets, and aorta of the streptozotocin-induced diabetic rat. Metabolism 11:1065-1072, 1988
37. Hagve TA: Effects of unsaturated fatty acids on cell membrane functions. Scand J Clin Lab Invest 48:381-388, 1988
38. Yorek M, Leeney E, Dunlap J, Ginsberg B: Effect of fatty acid composition on insulin and IGF-1 binding in retinoblastoma cells. Invest Ophthalmol Vis Sci 30:2087-2092, 1989
39. Ginsberg BH, Chaterjee P, Yorek M: Increased membrane fluidity is associated with greater sensitivity to insulin (Abstract). Diabetes 36 (Suppl. 1):51A, 1987
40. Ginsberg BH, Jabour J, Spector AA: Effect of alterations in membrane lipid unsaturation on the properties of the insulin receptor of ehrlich ascites cells. Biochim Biophys Acta 690:157-164, 1982
41. Field CJ, Ryan EA, Thomson ABR, Cladinin MT: Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane. Biochem J 253:417-424, 1988
42. Grunfeld C, Baird KL, Kahn CR: Maintenance of 3T3-L1 cells in culture media containing saturated fatty acids decreases insulin binding and insulin action. Biochem Biophys Res Commun 103:219-226, 1981
43. Lerique B, Lepetit-Thévenin J, Vérine A, Delpéro C, Boyer J: Triacylglycerol in biomembranes. Life Sci 54:831-840, 1994
44. Lillioja S, Mott DM, Zawadski JK, Young AA, Abbott WGH, Knowler WC, Bennett PH, Moll P, Bogardus C: In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 36:1329-1335, 1987
45. Knowler WC, Williams RC, Pettitt DJ, Steinberg AG: Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am. J Hum Genet 43:520-526, 1988
46. Prochazka M, Lillioja S, Tait JF, Knowler WC, Mott DM, Spraul M, Bennett PH, Bogardus C: Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 42:514-519, 1993
47. Alegret M, Cerqueda E, Ferrando R, Vázquez M, Sánchez RM, Adzet T, Merlos M, Laguna JC: Selective modification of rat hepatic microsomal fatty acid chain elongation and desaturation by fibrates: relationship with peroxisome proliferation. Br J Pharmacol 114:1351-1358, 1995